Latest Financial Health News

Page 14 of 85
Appen Limited delivered a robust Q4 FY25, driven by explosive growth in its China segment and strong gains in generative AI projects globally, boosting revenue and profitability significantly.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Horizon Oil reported an 18% rise in production and sales volumes in Q2 FY26, driven by its first full quarter of Thailand asset output. The company also maintained strong cashflow, paid a final FY25 dividend, and secured a long-term gas supply agreement in Australia’s Northern Territory.
Maxwell Dee
Maxwell Dee
29 Jan 2026
D3 Energy has reported encouraging progress in its South African helium and methane operations, highlighted by improved gas flow rates from the Nooitgedacht Major well and an upgraded US OTCQX listing to broaden investor reach.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.
Ada Torres
Ada Torres
29 Jan 2026
Li-S Energy has made significant strides in Q4 2025, securing a major government grant, forging key defence partnerships, and commissioning Australia’s first lithium foil production line.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Perpetual Limited’s second quarter FY26 update reveals a mixed performance with strong Corporate Trust growth balancing net outflows in Asset Management, while Wealth Management remains stable amid ongoing sale talks.
Claire Turing
Claire Turing
29 Jan 2026
Lark Distilling Co. has reported its sixth consecutive quarter of sales growth, with net sales rising 11% to $5 million in Q2 FY26, as it prepares to launch a refreshed brand portfolio domestically and internationally.
Victor Sage
Victor Sage
29 Jan 2026
ImpediMed reported a solid Q2 FY26 with $3.9 million in revenue and significant reimbursement gains for its lymphoedema technology, while launching new US Heart Health and Wellness initiatives.
Ada Torres
Ada Torres
29 Jan 2026
Vitrafy Life Sciences has marked significant progress in Q2 FY2026 with a strategic partnership, commercial launch in North America, and advancing clinical trials, underpinning its growth in cryopreservation technology.
Ada Torres
Ada Torres
29 Jan 2026
Mandrake Resources advances its Utah Lithium Project with a significant 3.3Mt lithium carbonate equivalent inferred resource, alongside key agreements for lithium offtake and uranium recovery.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Adslot Ltd reported steady trading for Q2 FY26, highlighting progress in its StoreFront platform roll-out and a promising new partnership with Infomo. The company also posted positive cash flow and significant cost savings.
Sophie Babbage
Sophie Babbage
28 Jan 2026
E79 Gold Mines Limited reported a solid quarter with a $3.1 million equity raise, ending December 2025 with $3.58 million in cash despite ongoing operating losses.
Maxwell Dee
Maxwell Dee
28 Jan 2026